NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
半胱天冬酶在多能胚胎干细胞中的非凋亡作用
基本信息
- 批准号:8269736
- 负责人:
- 金额:$ 30.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectApoptosisApoptoticCaspaseCell DeathCellsCleaved cellClinicalDevelopmentDevelopmental BiologyDiseaseEnzymesGoalsHuman bodyIn VitroKnock-outLinkMeasuresMediatingMediator of activation proteinMolecularPathway interactionsPhenotypePluripotent Stem CellsProcessProteinsRegenerative MedicineRegulationResistanceRoleSignal TransductionSmall Interfering RNASystemTestingUndifferentiatedWorkcaspase-3caspase-9cell typedrug discoveryembryonic stem cellgenetic regulatory proteininsightloss of functionmutantpluripotencyregenerative therapyresearch studyself-renewalsmall hairpin RNAstem cell differentiationstem cell divisionstem cell fatetooltranscription factortransplantation medicine
项目摘要
Embryonic stem (ES) cells are pluripotent and can expand in vitro without any apparent limits, while retaining
their ability to become any type of cell in the body. The long-term goal of this proposal is to link the molecular
mechanisms of programmed cell death to those underlying ES cell renewal and differentiation, with a view
toward accelerating the clinical introduction of ES cell regenerative medicine. In my preliminary studies, I
found that caspase-3, an important mediator of programmed cell death, has an unexpected role in controlling
ES cell fate. I demonstrate an increase of caspase-3 activity upon induction of differentiation and show that
caspase-3 can directly cleave the Nanog transcription factor, leading to rapid loss of this core pluripotency-
related protein and subsequent ES cell differentiation it typically mediates. These results suggest that caspase-
3 and perhaps other key components of the programmed cell death pathway may have an integral role in the
regulation of ES cell renewal/differentiation.
The central hypothesis of this proposed work is that classical mediators of programmed cell death, especially
caspase-3, also mediate the fate decisions affecting pluripotent stem cells. In Aim 1 I will dissect the functional
roles of caspase-3 and its activating caspase in the fate of ES cells. In Aim 2 I will modulate caspase activity
in ES cells and assess the effects on self-renewal, differentiation and programmed cell death. I will also
address the question of whether the differentiation-promoting activity of caspase-3 in ES cells is due to an
instructive or selective signaling and elucidate if caspase activity provides a specific signal to differentiate or
simply promotes differentiation in general. In Aim 3 I will assess the importance of caspase-3-mediated
cleavage of Nanog in ES cell differentiation. I consider the transcription factor Nanog to be a paradigm for
other potential caspase targets in ES cells, so that my findings for this regulatory protein could well extend to
other transcriptional pathways involved in ES cell differentiation.
Results of the experiments described in this proposal are expected to provide insight into the pleiotropic effects
of caspases in pluripotent stem cells. Thus, specific pharmacological alteration of caspases may be useful not
only for modulating apoptosis, but also for directing stem cell fate. The involvement of caspases in
nonapoptotic pathways suggests that efforts to block apoptosis via caspase inhibition could have much
broader consequences than initially thought. The ability of embryonic stem cells to remain undifferentiated in culture while retaining the ability to become
any cell within the human body make them an invaluable tool for use in transplant medicine, drug discovery,
and understanding basic developmental biology. Results of the experiments described in this proposal are
expected to provide insight into the pleiotropic effects of the cell death enzyme caspase on the differentiation
process of embryonic stem cells. Specific pharmacological alteration of caspases may be useful not only for
modulating programmed cell death, but also for directing stem cell fate.
胚胎茎(ES)细胞具有多能,可以在体外扩展而无明显限制,同时保持
它们成为体内任何类型的细胞的能力。该提议的长期目标是将分子联系起来
对基础ES细胞更新和分化的人的编程细胞死亡机制,
为了加速ES细胞再生医学的临床引入。在我的初步研究中,我
发现caspase-3是程序性细胞死亡的重要介体,在控制中具有意想不到的作用
ES细胞命运。我证明了caspase-3活性在诱导后的增加,并表明
caspase-3可以直接裂解纳米转录因子,从而导致这种核心多能的迅速丧失 -
相关蛋白质和随后的ES细胞分化通常会介导。这些结果表明caspase-
3也许是程序性细胞死亡途径的其他关键组成部分可能在
ES细胞更新/分化的调节。
这项拟议工作的核心假设是,编程细胞死亡的经典介体,尤其是
caspase-3,还介导影响多能干细胞的命运决定。在AIM 1中,我将剖析功能
caspase-3的作用及其在ES细胞命运中的激活caspase。在AIM 2中,我将调节caspase活动
在ES细胞中,评估对自我更新,分化和程序性细胞死亡的影响。我也会
解决了ES细胞中caspase-3的分化促进活性的问题
启发性或选择性信号传导并阐明caspase活动是否提供了特定的信号来区分或
一般而言,简单地促进分化。在AIM 3中,我将评估caspase-3介导的重要性
ES细胞分化中纳米的切割。我认为转录因子nanog是
ES细胞中其他潜在的caspase靶标,以便我对这种调节蛋白的发现可以很好地延伸到
ES细胞分化涉及的其他转录途径。
预计本提案中描述的实验结果将提供对多效效应的见解
多能干细胞中的胱天蛋白酶。因此,胱天蛋白酶的特定药理改变可能是有用的
仅用于调节细胞凋亡,还用于指导干细胞命运。胱天蛋白酶参与
非凋亡途径表明,通过caspase抑制阻止凋亡的努力可能具有很多
比最初想象的更广泛的后果。胚胎干细胞在培养中保持未分化的能力,同时保持变为
人体内的任何细胞都使它们成为用于移植药物,药物发现的宝贵工具,
并了解基本的发展生物学。本提案中描述的实验结果是
预计将深入了解细胞死亡酶caspase对分化的多效性影响
胚胎干细胞的过程。 caspases的特定药理改变不仅对
调节程序性细胞死亡,但也用于指导干细胞命运。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells.
- DOI:10.1371/journal.pbio.1001268
- 发表时间:2012
- 期刊:
- 影响因子:9.8
- 作者:Jain AK;Allton K;Iacovino M;Mahen E;Milczarek RJ;Zwaka TP;Kyba M;Barton MC
- 通讯作者:Barton MC
Generation of hiPSTZ16 (ISMMSi003-A) cell line from normal human foreskin fibroblasts.
从正常人包皮成纤维细胞生成 hiPSTZ16 (ISMMSi003-A) 细胞系。
- DOI:10.1016/j.scr.2017.11.019
- 发表时间:2018
- 期刊:
- 影响因子:1.2
- 作者:Dejosez,Marion;Zwaka,ThomasP
- 通讯作者:Zwaka,ThomasP
Ronin influences the DNA damage response in pluripotent stem cells.
- DOI:10.1016/j.scr.2017.06.014
- 发表时间:2017-08
- 期刊:
- 影响因子:1.2
- 作者:Seifert BA;Dejosez M;Zwaka TP
- 通讯作者:Zwaka TP
Single-cell analysis of transcription kinetics across the cell cycle.
- DOI:10.7554/elife.12175
- 发表时间:2016-01-29
- 期刊:
- 影响因子:7.7
- 作者:Skinner SO;Xu H;Nagarkar-Jaiswal S;Freire PR;Zwaka TP;Golding I
- 通讯作者:Golding I
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas P. Zwaka其他文献
Thomas P. Zwaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas P. Zwaka', 18)}}的其他基金
Bat pluripotent stem cells as a novel experimental system
蝙蝠多能干细胞作为一种新型实验系统
- 批准号:
10592777 - 财政年份:2023
- 资助金额:
$ 30.09万 - 项目类别:
Protection of early embryogenesis and pluripotent stem cells against genetic parasites through a primitive immune system
通过原始免疫系统保护早期胚胎发生和多能干细胞免受遗传寄生虫的侵害
- 批准号:
10356153 - 财政年份:2020
- 资助金额:
$ 30.09万 - 项目类别:
Protection of early embryogenesis and pluripotent stem cells against genetic parasites through a primitive immune system
通过原始免疫系统保护早期胚胎发生和多能干细胞免受遗传寄生虫的侵害
- 批准号:
10570214 - 财政年份:2020
- 资助金额:
$ 30.09万 - 项目类别:
An inquiry into the function of Ronin in embryogenesis and pluripotent stem cells
Ronin在胚胎发生和多能干细胞中的功能探究
- 批准号:
9897561 - 财政年份:2018
- 资助金额:
$ 30.09万 - 项目类别:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
半胱天冬酶在多能胚胎干细胞中的非凋亡作用
- 批准号:
7826576 - 财政年份:2008
- 资助金额:
$ 30.09万 - 项目类别:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
半胱天冬酶在多能胚胎干细胞中的非凋亡作用
- 批准号:
7655456 - 财政年份:2008
- 资助金额:
$ 30.09万 - 项目类别:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
半胱天冬酶在多能胚胎干细胞中的非凋亡作用
- 批准号:
8073463 - 财政年份:2008
- 资助金额:
$ 30.09万 - 项目类别:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
半胱天冬酶在多能胚胎干细胞中的非凋亡作用
- 批准号:
7522733 - 财政年份:2008
- 资助金额:
$ 30.09万 - 项目类别:
Thanatos-Associated Protein 11 (Thap11) in Human Embryonic Stem Cells
人胚胎干细胞中的死亡相关蛋白 11 (Thap11)
- 批准号:
7356524 - 财政年份:
- 资助金额:
$ 30.09万 - 项目类别:
Thanatos-Associated Protein 11 (Thap11) in Human Embryonic Stem Cells
人胚胎干细胞中的死亡相关蛋白 11 (Thap11)
- 批准号:
7678452 - 财政年份:
- 资助金额:
$ 30.09万 - 项目类别:
相似国自然基金
VNN1通过内质网非折叠蛋白应激介导单核巨噬细胞凋亡影响创伤患者脓毒症发生的机制研究
- 批准号:82372549
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
EHMT1通过CBX4/MLKL轴调控心肌细胞坏死性凋亡影响心肌缺血再灌注损伤的机制研究
- 批准号:82370288
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
MLCK1介导细胞凋亡和自噬影响炎症性肠病进展
- 批准号:82370568
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
草鱼贮藏过程肌细胞凋亡对鱼肉品质的影响机制研究
- 批准号:32372397
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
应激颗粒自噬对低氧诱导猪卵泡颗粒细胞凋亡的影响及机制研究
- 批准号:32302741
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 30.09万 - 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 30.09万 - 项目类别:
Catheter-injectable system for local drug delivery after myocardial infarct
用于心肌梗死后局部给药的导管注射系统
- 批准号:
10722614 - 财政年份:2023
- 资助金额:
$ 30.09万 - 项目类别:
Translational Multimodal Strategy for Peri-Implant Disease Prevention
种植体周围疾病预防的转化多模式策略
- 批准号:
10736860 - 财政年份:2023
- 资助金额:
$ 30.09万 - 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 30.09万 - 项目类别: